Table 2.
Effect of sensitivity analysis on policy recommendation (n = 33)
| No. | First author, year | Policy recommendation | |||
|---|---|---|---|---|---|
| Base case analysisa | CVG | Screening coverage | Vaccination coverage | ||
| 1 | Aponte-Gonzalez et al. 2013 [20] | − | + | NA | NA |
| 2 | Berkhof et al. 2013 [21] | +b | NA | + | NA |
| 3 | Campos et al. 2012 [22] | + | − | + | + |
| 4 | Canfell et al. 2011 [23] | NA | NA | NA | NA |
| 5 | Colantonio et al. 2009 [24] | + | NA | + | NA |
| 6 | Diaz et al. 2008 [25] | + | − | NA | NA |
| 7 | Fonseca et al. 2013 [26] | + | NA | NA | − |
| 8 | Ginsberg et al. 2009 [27] | + | − | NA | NA |
| 9 | Goldie et al. 2007 [30] | + | − | NR | NR |
| 10 | Goldie et al. 2008 [28] | + | − | NA | NR |
| 11 | Goldie et al. 2008 [29] | + | − | NR | NR |
| 12 | Goldie et al. 2008 [32] | +b | − | NR | NR |
| 13 | Goldie et al. 2012 [31] | + | + | NA | NA |
| 14 | Gutierrez-Aguado, 2011 [33] | + | + | NA | NA |
| 15 | Gutierrez-Delgado et al. 2008 [34] | − | + | NA | NA |
| 16 | Insinga et al. 2007 [35] | + | NA | NA | − |
| 17 | Jit et al. 2014 [36] | NA | NA | NA | NA |
| 18 | Kawai et al. 2012 [37] | + | NR | NA | NA |
| 19 | Khatibi et al. 2014 [38] | − | − | NA | NA |
| 20 | Kiatpongsan and Kim, 2014 [39] | NA | NA | NA | NA |
| 21 | Kim et al. 2007 [40] | + | − | NA | + |
| 22 | Kim et al. 2008 [42] | + | − | − | − |
| 23 | Kim et al. 2011 [44] | NA | NA | NA | NA |
| 24 | Kim et al. 2013 [41] | +b | − | NR | NR |
| 25 | Kim et al. 2013 [43] | +b | − | NR | NR |
| 26 | Levin et al. 2015 [45] | + | + | NR | + |
| 27 | Praditsitthikorn et al. 2011 [46] | − | +c | + | − |
| 28 | Reynales-Shigematsu et al. 2009 [47] | + | − | NR | − |
| 29 | Sharma et al. 2012 [48] | + | − | + | + |
| 30 | Sinanovic et al. 2009 [49] | +c | +d | NA | NA |
| 31 | Termrungruanglert et al. 2012 [50] | + | − | NA | + |
| 32 | Tracy et al. 2014 [51] | + | NA | NA | + |
| 33 | Vanni et al. 2012 [52] | + | − | + | + |
| Number of studies that parameter uncertainty affected policy recommendation | 18 | 2 | 4 | ||
| Number of studies that did not report the effect of parameter uncertainty | 1 | 7 | 6 | ||
+ Accept vaccination, − reject vaccination, CVG cost per vaccinated girl, NA not applicable, NR not reported
aSome studies were denoted NA since the primary focus was to explore price range for which vaccine would be cost-effective or to develop a generic model for cost-effectiveness analysis
bMajority of the countries in multi-country study
cAccept vaccination in combination with screening
dVaccine is more cost-effective than screening